본문 바로가기
KERD
논문KCI 등재

권역심뇌혈관질환센터 사업의 비용-편익 분석

Cost-Benefit Analysis of Regional Cardiocerebrovascular Center Projects

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Objectives: This study was conducted to investigate economic feasibility of operating Regional Cardiocerebrovascular Centers using cost-benefit analysis. Methods: The current study assessed cost and benefit data collected from nine hospitals which were designated as Regional Cardiocerebrovascular Centers between 2008 and 2010. Results: The operation of Regional Cardiocerebrovascular Centers reduced mortality rate and length of stay due to acute myocardial infarction and stroke and also decreased disability occurred after stroke. The total calculated cost of operating nine Regional Cardiocerebrovascular Centers was 19.85-22.30 billion won and the minimum benefit calculated was 23.98 billion won. Applying the maximum cost and the minimum benefit, the net benefit was 1.68 billion won, which is estimated to 190 million won per Regional Cardiocerebrovascular Center. Conclusions: The present study revealed that the operation of Regional Cardiocerebrovascular Centers was economically beneficial. The benefit would be larger if intangible benefit such as the long-term effects to community hospitals and enhancement of quality of life of patients and their families are considered.

Abstract

Objectives: This study was conducted to investigate economic feasibility of operating Regional Cardiocerebrovascular Centers using cost-benefit analysis. Methods: The current study assessed cost and benefit data collected from nine hospitals which were designated as Regional Cardiocerebrovascular Centers between 2008 and 2010. Results: The operation of Regional Cardiocerebrovascular Centers reduced mortality rate and length of stay due to acute myocardial infarction and stroke and also decreased disability occurred after stroke. The total calculated cost of operating nine Regional Cardiocerebrovascular Centers was 19.85-22.30 billion won and the minimum benefit calculated was 23.98 billion won. Applying the maximum cost and the minimum benefit, the net benefit was 1.68 billion won, which is estimated to 190 million won per Regional Cardiocerebrovascular Center. Conclusions: The present study revealed that the operation of Regional Cardiocerebrovascular Centers was economically beneficial. The benefit would be larger if intangible benefit such as the long-term effects to community hospitals and enhancement of quality of life of patients and their families are considered.

참고문헌 (28)

  1. The Korean society of preventive medicine, "medicine and public health", pp.358~363 (2015), Gyechuk munwhasa
  2. "Annual report on the cause of death statistics 2014"[URL]
  3. Main diseases and health behaviors analysis in Koreans. 2001 Korea national health and nutrition survey in-depth analysis result, "Kim JY", Korea Institute for Health and Social Affairs, 445~458 (2003)
  4. Gold MR, "Cost-effectiveness in health and medicine" (1996), Oxford University Press
  5. Kim J, "Establishment of government-initiated comprehensive stroke centers for acute ischemic stroke management in South Korea", Stroke, 45(8), pp.2391~2396 (2014)
  6. Development of clinical registry system and cost-effcetiveness analysis in people with cardiocerebrovascualr disease in Registry Cardiocerebrovascualr disease center, "Lim BH", Korea Centers for Disease Control and Prevention, 297~420 (2014)
  7. 홍근식, "Stroke Statistics in Korea: Part II Stroke Awareness and Acute Stroke Care, A Report from the Korean Stroke Society and Clinical Research Center For Stroke", 대한뇌졸중학회지, 15(2), pp.67~77 (2013), 대한뇌졸중학회[DOI]
  8. Jung KH, "Secular trends n ischemic stroke characteristics in a rapidly developed country results from the Korean Stroke Registry Study (secular trends in Korean stroke)", Circ Cardiovasc Qual Outcomes, 5(3), pp.327~334 (2012)
  9. Campbell BCV, "Twenty-year history of the evolution of stroke thrombolysis with intravenous alteplase to reduce long-term disability", Stroke, 46(8), pp.2341~2346 (2015)
  10. Lansberg MG, "Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale", Stroke, 40(6), pp.2079~2084 (2009)
  11. Goyal M, "Randomized assessment of rapid endovascular treatment of ischemic stroke", N Engl J Med, 372, pp.1019~1030 (2015)
  12. Berkhemer OA, "A randomized trial of intraarterial treatment for acute ischemic stroke", N Engl J Med, 372, pp.11~20 (2015)
  13. Brønnum-Hansen H, "Long-term survival and causes of death after stroke", Stroke, 32(9), pp.2131~2136 (2001)
  14. Boysen G, "Longterm survival after stroke: 30 years of follow-up in a cohort, the Copenhagen City Heart Study", Neuroepidemiology, 33(3), pp.254~260 (2009)
  15. Han DS, "Predictors of long-term survival after stroke in Taiwan", J Rehabil Med, 40(10), pp.844~849 (2008)
  16. Chausson N, "Five-year outcome of a stroke cohort in Martinique, French West Indies: Etude Réalisée en Martinique et Centrée sur l’Incidence des Accidents vasculaires cérebraux, Part 2", Stroke, 41(4), pp.594~599 (2010)
  17. Dhamoon MS, "Long-term functional recovery after first ischemic stroke the northern manhattan study", Stroke, 40(8), pp.2805~2811 (2009)
  18. 임지혜, "뇌졸중 환자의 사망 추적연구", 대한의사협회지, 54(11), pp.1199~1208 (2011), 대한의사협회
  19. 윤태호, "장애 유형별 의료서비스 이용의 차이", 보건행정학회지, 17(2), pp.33~51 (2007), 한국보건행정학회
  20. Korea National Health Insurance Service, "2012 National health insurance statistical yearbook" (2013), Korea National Health Insurance Service
  21. "Employment and labour statistics"[URL]
  22. "The Korea Patient Helper Society"[URL]
  23. Kim JY, "Construction of national surveillance system for cardiovascular & cerebrovascular diseases", Health Insurance Review Agency, 147~204 (2006)
  24. Korea National Health Insurance Service, "2015 Long term care insurance statistical yearbook" (2016), Korea National Health Insurance Service
  25. Korea medical panel basic analysis report, "Korea National Health Insurance Service", Korea National Health Insurance Service, 89~90 (2013)
  26. Social cost-benefit analysis of the establishment of emergency medical care system, "Lee SH", Korea Health Industry Development Institute, 58~121 (2008)
  27. Cost-benefit analysis of operating City Health Sub-center, "Kam S", Korea Health Industry Development Institute, ~ (2007)
  28. Community-based hypertension and diabetes management program development for improving adherence and compliance using registry-based information system, "Lee KS", Korea Center for Disease Control and Prevention, ~ (2007)

관련 논문AI추천

이 간행물의 다른 논문 (10건)